When someone you love needs surgery, it's natural to focus on getting them safely through the procedure. But for many family caregivers, the harder moments start at home, in those first days after discharge, when the care team is no longer just down the hall. As National Family Caregivers Month recognizes the people who care for loved ones at home, we need to pay closer attention to what they need to feel supported during those early days of recovery.
New findings from the Ready, Set, Recover initiative, launched by Pacira BioSciences, Inc. and Caregiver Action Network (CAN), suggest many caregivers step into this role with more questions than answers. The survey asked 202 caregivers about their experience with surgery preparation, postsurgical pain, and recovery at home. Nearly half (45%) had provided care for more than six months, and around eight in 10 (78%) agreed that caregivers are often expected to manage pain at home without enough support or information.
Before Surgery, Caregivers Face an Information Gap
Only a few of the caregivers surveyed said they had the information they needed before the procedure. Only 19% received comprehensive details about pain management options ahead of time, while roughly four in five (81%) received only some information, very little, or none.
Awareness of non-opioid options was also uneven, with one-third (33%) of caregivers either unaware of these options or not familiar with them. Encouragingly, nearly three-quarters (72%) said they would have considered or requested a different pain management approach if they had received more information beforehand.
A Caregiver Who Knew What to Ask
Lisa Bright knows that uncertainty well, and through years of advocacy, she has also learned about the different ways pain can be managed after surgery. When her husband, Bill, needed foot surgery, they were both determined to find a non-opioid option for managing his pain, but they had to take the lead in researching options and starting the conversation with his physician.
Their efforts ultimately led them to EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, non-opioid local anesthetic administered at the time of surgery. Lisa also had to pick up the medication from a pharmacy, pack it in a cooler and bring it to the surgery center for his care team to administer – this is not the standard method for obtaining EXPAREL, as it is typically provided to patients by their healthcare provider. Injected directly into the surgical site, EXPAREL slowly releases medication to provide targeted, long-lasting pain relief during the first few days after surgery. Lisa observed how EXPAREL began managing her husband’s pain as soon as he woke up, allowing them both to ease into the recovery process.
“Little things like that make a big difference when you're trying to get somebody settled,” she said.
For the Brights, questions about pain medication often carry extra weight, as their son, Will, passed away at age 25 after years of struggling with opioid addiction. The couple started the Will Bright Foundation, in his memory, to help people transition from addiction treatment to long-term recovery. In addition to serving as CEO of the Will Bright Foundation, Lisa serves on the board of Voices for Non-Opioid Choices, a nonpartisan coalition working to increase access to non-opioid pain management.
She is quick to point out that their advocacy work is the reason her family knew to ask at all. Other caregivers, who lack background knowledge of non-opioid medications, may be more in the dark. “How unfair is that?” she said, “People just don't know.”
Lisa also understands that these conversations have not always been easy for families. She remembers a time when asking about alternatives to opioids could bring stigma or cause people to make assumptions about the patient. Now, she urges caregivers to talk openly with the care team and ask about available options.
Planning for Recovery at Home
For many caregivers, the need for guidance continues long after they leave the hospital. Once a loved one is home, the questions can multiply. About half of the caregivers surveyed (51%) as part of Ready, Set, Recover were concerned about knowing when and how to safely reduce or stop pain medication.
When asked what would help them feel more prepared, caregivers highlighted the value of practical resources like a checklist or daily care plan (63%), as well as ongoing access to a healthcare provider after discharge (53%). Importantly, 82% said that their involvement and questions played a meaningful role in shaping their loved one's pain management and recovery plan.
As we recognize National Family Caregivers Month, these insights underscore the importance of including caregivers in pre-surgery pain management discussions, so they have time to ask questions and consider all options. We encourage patients and caregivers to connect with their healthcare provider ahead of surgery to explore pain management approaches that may be right for them, including non-opioid alternatives.
“Don't feel intimidated when you're in front of a doctor or a nurse," Lisa encouraged. "Don't let it become a stigma issue. Make sure you really understand what the aftercare is."
As more families learn what to ask for and how to plan their road to recovery, the path from the hospital to home can feel less uncertain for patients and those who love and care for them. See the full Ready, Set, Recover findings here.
*Lisa Bright is a spokesperson for the Ready, Set, Recover initiative. Her comments are based on her personal and professional experiences. Individual patient experiences may vary.
INDICATION
EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa, and an adductor canal block. Safety and efficacy have not been established in other nerve blocks.
IMPORTANT SAFETY INFORMATION
EXPAREL should not be used in obstetrical paracervical block anesthesia.
In studies in adults where EXPAREL was injected into a wound, the most common side effects were nausea, constipation, and vomiting.
In studies in adults where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, headache, and constipation.
In the study where EXPAREL was given to children, the most common side effects were nausea, vomiting, constipation, low blood pressure, low number of red blood cells, muscle twitching, blurred vision, itching, and rapid heartbeat.
EXPAREL can cause a temporary loss of feeling and/or loss of muscle movement. How much and how long the loss of feeling and/or muscle movement depends on where and how much of EXPAREL was injected and may last for up to 5 days.
EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, and/or in pregnant women.
Tell your health care provider if you or your child has liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from the body.
EXPAREL should not be injected into the spine, joints, or veins.
The active ingredient in EXPAREL can affect the nervous system and the cardiovascular system; may cause an allergic reaction; may cause damage if injected into the joints; and can cause a rare blood disorder.
Please refer to full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
###
© 2026 Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc. EXPAREL is a registered trademark of Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc. All rights reserved.
PP-EX-US-10791 10/26
